TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10856864

Group type: EXPERIMENTAL
Intervention: Mini-right anterolateral thoracotomy (test group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Median sternotomy (control group)
Number of subjects: 100
Study: 9663358

Group type: EXPERIMENTAL
Intervention: Hylan G-F 20 (2 mL, three intra-articular injections, 1 week apart)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Physiologic buffered saline solution (2 mL, three injections at the same intervals)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Hylan G-F 20
Number of subjects: 117

Group type: COMPARATOR
Intervention: Physiologic buffered saline solution
Number of subjects: 117
Study: 7930740

Group type: COMPARATOR
Intervention: Mitogen stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egg antigens stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adult worm antigen stimulation
Number of subjects: 0
Study: 2856597

Group type: EXPERIMENTAL
Intervention: cimetidine 300 mg QID
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: cimetidine 800 mg HS
Number of subjects: 338

Group type: COMPARATOR
Intervention: ranitidine 300 mg HS
Number of subjects: 338
Study: 30030456

Group type: EXPERIMENTAL
Intervention: narrative-AVG
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: AVG
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: narrative-SVG
Number of subjects: 4

Group type: COMPARATOR
Intervention: SVG
Number of subjects: 4
Study: 28109467

Group type: EXPERIMENTAL
Intervention: Dexamethasone (60mg total over three days)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (no dexamethasone)
Number of subjects: 93
Study: 25705653

Group type: EXPERIMENTAL
Intervention: DBM injection (n = 14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional treatment without injection (n = 15)
Number of subjects: 29
Study: 23159586

Group type: EXPERIMENTAL
Intervention: Brief smoking cessation intervention
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Brief smoking cessation intervention plus nicotine replacement therapy
Number of subjects: 179

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 179
Study: 21176029

Group type: EXPERIMENTAL
Intervention: Uridine (2 g)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 18408090

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (Botox, 2x50 units)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16678893

Group type: EXPERIMENTAL
Intervention: Population program aimed at reducing dietary salt (half the intake of salt)
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Presentation of effectiveness format (NNT, RRR, avoided cases of heart attack, increase in longevity)
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Population program
Number of subjects: 924
Study: 12800416

Group type: EXPERIMENTAL
Intervention: Digoxin combined with 20 ml of Shengmai Injection (SMI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Digoxin combined with 40 ml of Shengmai Injection (SMI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Digoxin combined with 60 ml of Shengmai Injection (SMI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no Shengmai Injection)
Number of subjects: 40
Study: 10693631

Group type: EXPERIMENTAL
Intervention: Cytomegalovirus immune globulin (CMVIG) prophylaxis after OLT
Number of subjects: 0
Study: 9002785

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Plaque Remover‐D7
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Ultra Plaque Remover‐D9
Number of subjects: 24

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 24
Study: 1580290

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibition (Perindopril)
Number of subjects: 480
Study: 4077545

Group type: EXPERIMENTAL
Intervention: Self-Management Training Program (SCRPA) for school-age children (ages 6-14), consisting of eight 90-minute classes for both child and parent(s) scheduled twice a week for 4 weeks.
Number of subjects: 59

Group type: COMPARATOR
Intervention: Self-Management Training Program (SCRPA) for preschool children (ages 2-5), consisting of six 1-hour classes scheduled twice a week for 3 weeks.
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group for school-age children (ages 6-14).
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group for preschool children (ages 2-5).
Number of subjects: 59
Study: 31408467

Group type: EXPERIMENTAL
Intervention: Novel drink powder (4 g betaine, 800 μg folic acid, 5.2 μg vitamin B12, and 2.8 mg vitamin B2)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: UNIMMAP (widely used multiple micronutrient tablet containing 15 micronutrients)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Novel drink powder
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 298
Study: 28399016

Group type: EXPERIMENTAL
Intervention: Whey Protein Concentrate (WPC)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Beef Protein
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Hydrolyzed Chicken Protein (Chx)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Maltodextrin (Control)
Number of subjects: 41
Study: 26727095

Group type: EXPERIMENTAL
Intervention: Vagus nerve preserving distal gastrectomy (VPG)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Conventional distal gastrectomy (CG)
Number of subjects: 163
Study: 24322331

Group type: EXPERIMENTAL
Intervention: DZ1 (10-23 DNAzyme)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40
Study: 22873117

Group type: EXPERIMENTAL
Intervention: l-NAME (NO synthase inhibitor)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ringer's solution (control site)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ketorolac (COX pathway inhibitor)
Number of subjects: 14
Study: 20845218

Group type: EXPERIMENTAL
Intervention: 30 min of moderate-intensity cycling at approximately 60% of maximal heart rate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest (no exercise)
Number of subjects: 10
Study: 17259476

Group type: EXPERIMENTAL
Intervention: 4 g HV‐HPMC
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 8 g HV‐HPMC
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control meal (8 g cellulose)
Number of subjects: 31
Study: 15734080

Group type: EXPERIMENTAL
Intervention: Amoxicillin-sulbactam
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 12195172

Group type: EXPERIMENTAL
Intervention: Linear peak-clipper
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Linear compression limiter
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Wide dynamic range compressor
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Aided condition
Number of subjects: 360

Group type: COMPARATOR
Intervention: Unaided condition
Number of subjects: 360
Study: 10193824

Group type: EXPERIMENTAL
Intervention: Haemodialysis with a biocompatible membrane (polysulfone)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Haemodialysis with a bioincompatible membrane (cuprophane)
Number of subjects: 53
Study: 7762842

Group type: EXPERIMENTAL
Intervention: Adenosine infusion, 80 micrograms.kg-1.min-1
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Adenosine infusion
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 2268865

Group type: EXPERIMENTAL
Intervention: Slow‐K (wax-matrix tablet)
Number of subjects: 18

Group type: COMPARATOR
Intervention: K‐Dur (microencapsulated tablet)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Slow‐K
Number of subjects: 18

Group type: COMPARATOR
Intervention: K‐Dur
Number of subjects: 18
Study: 78384

Group type: EXPERIMENTAL
Intervention: E. coli H‐10407 (C.F.A.+) at a dose of 10(8)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: E. coli H‐10407 (C.F.A.+)
Number of subjects: 25

Group type: COMPARATOR
Intervention: E. coli H‐10407‐P (C.F.A.‐)
Number of subjects: 25
Study: 31368518

Group type: EXPERIMENTAL
Intervention: BF‐200 ALA
Number of subjects: 69

Group type: COMPARATOR
Intervention: MAL
Number of subjects: 69
Study: 29442466

Group type: EXPERIMENTAL
Intervention: Endometriosis group (EM)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Endometriosis stages III–IV
Number of subjects: 116
Study: 25664489

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) (n = 13) consisting of four 45‐second bouts with 1‐minute intervening rest periods (frequency: 50 Hz, amplitude: 2 mm)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham electrical stimulation (n = 12)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) and Sham electrical stimulation
Number of subjects: 25
Study: 23286423

Group type: EXPERIMENTAL
Intervention: 2-hour run at 75% VO(2 max)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 16
Study: 21704360

Group type: EXPERIMENTAL
Intervention: Individualized problem-solving (PS) intervention
Number of subjects: 333

Group type: COMPARATOR
Intervention: Standard asthma education (AE)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 333
Study: 19321868

Group type: EXPERIMENTAL
Intervention: Immediate circumcision (intervention group)
Number of subjects: 5534

Group type: COMPARATOR
Intervention: Circumcision after 24 months (control group)
Number of subjects: 5534
Study: 16306137

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG) electrolyte balanced solution, 29.5 g daily for 7 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo, similar to PEG, for 7 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PEG therapy
Number of subjects: 30
Study: 12769196

Group type: EXPERIMENTAL
Intervention: Videotape-brochure group
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Video only group
Number of subjects: 558

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 558
Study: 10786346

Group type: EXPERIMENTAL
Intervention: Topical diclofenac emulsion gel applied every 8 hours for 48 hours
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral diclofenac 75 mg p.o. every 12 hours for 48 hours
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study: 9381637

Group type: EXPERIMENTAL
Intervention: Likopide (10 mg tablets, orally, twice daily for 3 days, followed by a 3-day interval, then 3 days of treatment)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Likopide
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8239057

Group type: EXPERIMENTAL
Intervention: Padma 28 (340 mg, two tablets bid)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 3919831

Group type: EXPERIMENTAL
Intervention: Cisplatin 120 mg intravenously
Number of subjects: 86

Group type: COMPARATOR
Intervention: Cyclophosphamide 2 g intravenously
Number of subjects: 86
Study: 31814607

Group type: EXPERIMENTAL
Intervention: Antegrade endoscopic vein harvesting (EVH) from the lower leg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leg positioning and synergizing EVH with bridging vein harvesting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antegrade EVH from the lower leg
Number of subjects: 0
Study: 30357264

Group type: EXPERIMENTAL
Intervention: Intervention group (n=101) received a 5-day course involving nursing theory recap and situational role-play using simulated scenarios.
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (n=97) did not receive the intervention.
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Intervention group (n=101)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (n=97)
Number of subjects: 198
Study: 27852286

Group type: EXPERIMENTAL
Intervention: Best medical treatment plus extracranial-intracranial (EC-IC) bypass surgery
Number of subjects: 330

Group type: COMPARATOR
Intervention: Best medical treatment alone
Number of subjects: 330
Study: 25130149

Group type: EXPERIMENTAL
Intervention: Low-dose hCG (200 IU daily)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Non-hCG group
Number of subjects: 137
Study: 22090467

Group type: EXPERIMENTAL
Intervention: Dietary pattern (DP) including soy protein, nopal, chia seed, and oat, consumed for 2 months with a reduced energy diet (500 kcal reduction).
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (P) beverage, consumed for 2 months with a reduced energy diet (500 kcal reduction).
Number of subjects: 67
Study: 20090953

Group type: EXPERIMENTAL
Intervention: Audio Computer Assisted Self Interview (ACASI)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Self-Administered Questionnaire (SAQ)
Number of subjects: 758
Study: 17392718

Group type: EXPERIMENTAL
Intervention: St John's wort (SJW) 900 mg daily for 12 days
Number of subjects: 9
Study: 15629592

Group type: EXPERIMENTAL
Intervention: High-source strength implants (0.76 microGy/m(2)/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-source strength implants (0.4 microGy/m(2)/h)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-source strength implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-source strength implants
Number of subjects: 40
Study: 12154266

Group type: EXPERIMENTAL
Intervention: Aortic stiffness index beta in stroke patients (9.7+/‐5.0)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Aortic stiffness index beta
Number of subjects: 82
Study: 10469077

Group type: COMPARATOR
Intervention: 20% hypertonic saline (HS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 1% polidocanol (POL)
Number of subjects: 81
Study: 8527550

Group type: EXPERIMENTAL
Intervention: Permethrin-impregnated uniforms
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control uniforms (washed in water)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control uniforms (not impregnated)
Number of subjects: 229
Study: 1983106

Group type: EXPERIMENTAL
Intervention: 2% carteolol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.6% metipranolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7027750

Group type: EXPERIMENTAL
Intervention: Initial dose of glipizide (5 mg p.o.)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Long-term treatment with glipizide (range 7.5‐20 mg, mean 10.4 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Single dose regime
Number of subjects: 13

Group type: COMPARATOR
Intervention: Three-part divided dose regime
Number of subjects: 13

Group type: COMPARATOR
Intervention: Single dose and divided dose regimes
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Glipizide
Number of subjects: 13
Study: 31634870

Group type: EXPERIMENTAL
Intervention: Silymarin 140 mg every 8 hours for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group receiving standard treatments
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Silymarin group
Number of subjects: 80
Study: 31043521

Group type: EXPERIMENTAL
Intervention: Balovaptan 4 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Balovaptan 10 mg
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 28422628

Group type: EXPERIMENTAL
Intervention: Occupational Performance Coaching for stroke survivors (OPC‐Stroke)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 21
Study: 25482469

Group type: EXPERIMENTAL
Intervention: Local infiltration of 20 mL bupivacaine 0.25%
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo group (20 mL saline 0.9%)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Both groups (bupivacaine vs saline)
Number of subjects: 357
Study: 24494521

Group type: EXPERIMENTAL
Intervention: Titanium Elastic Nails (TEN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traction with spica casting
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 21342412

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg + Metformin 500 mg
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: Saxagliptin 10 mg + Metformin 500 mg
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Saxagliptin 10 mg
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Metformin 500 mg
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: Saxagliptin + Metformin
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1306
Study: 19087002

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.08%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.10%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.12%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.14%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.16%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.18%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 60
Study: 18245399

Group type: EXPERIMENTAL
Intervention: Developmental care (incubator covers and positioning aids)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control (standard care, no covers or nests)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Developmental care
Number of subjects: 179
Study: 16131291

Group type: EXPERIMENTAL
Intervention: Stimulation acupressure treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation acupressure treatment
Number of subjects: 0
Study: 12383985

Group type: EXPERIMENTAL
Intervention: SRL172
Number of subjects: 760

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760
Study: 10022558

Group type: EXPERIMENTAL
Intervention: Eccentric training (5x6 eccentric muscle actions at 100 and 120% of one maximal repetition (IRM) for 21 sessions over 7 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 17
Study: 7759725

Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Percutaneous coronary angioplasty
Number of subjects: 1012
Study: 2107214

Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 19
Study: 7360548

Group type: EXPERIMENTAL
Intervention: Additional information about the sensory capacity of neonates
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Additional postpartum contact with their infants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Age group 19 years and older
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Age group 18 years and younger
Number of subjects: 40
Study: 29182415

Group type: EXPERIMENTAL
Intervention: Hammer Cycle Ergometer
Number of subjects: 11
Study: 26869311

Group type: EXPERIMENTAL
Intervention: High irrigation pressure (200 mm Hg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low irrigation pressure (80 mm Hg)
Number of subjects: 90
Study: 23981104

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg (one to three times daily)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study: 22252545

Group type: EXPERIMENTAL
Intervention: Supervised exercise program for 12 months
Number of subjects: 69
Study: 20157016

Group type: EXPERIMENTAL
Intervention: Mail and telephone intervention consisting of mailings, telephone calls, and counseling (if requested or appropriate given a woman's genetic risk for breast cancer)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 0
Study: 18548841

Group type: EXPERIMENTAL
Intervention: Ketamine (0.2 mL injection)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (buffered isotonic saline, 155 mmol/L)
Number of subjects: 14
Study: 16800990

Group type: EXPERIMENTAL
Intervention: Wuye Decoction (WYD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (no specific medicine)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Healthy volunteers (Group C)
Number of subjects: 82
Study: 12548305

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 214

Group type: COMPARATOR
Intervention: Face-to-face interview
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 214
Study: 10550755

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 20 mg twice a day
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 60 mg twice a day
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 120 mg twice a day
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 240 mg twice a day
Number of subjects: 439

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study: 8983283

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 111

Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Ceftazidime and/or Imipenem
Number of subjects: 111
Study: 1955603

Group type: EXPERIMENTAL
Intervention: Genital condition (vaginal and anal examination)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nongenital condition (scoliosis examination)
Number of subjects: 72
Study: 7318355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indoramin
Number of subjects: 20
Study: 30684769

Group type: EXPERIMENTAL
Intervention: Implementation of 29 evidence-based nursing recommendations for conservative management of UI
Number of subjects: 381
Study: 27993287

Group type: EXPERIMENTAL
Intervention: rehabilitation plus B12 group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: B12 group
Number of subjects: 32

Group type: COMPARATOR
Intervention: rehabilitation group
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo group
Number of subjects: 32
Study: 24285576

Group type: EXPERIMENTAL
Intervention: Penile vibratory stimulation (PVS) for the first 6 weeks (group 1)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Penile vibratory stimulation (PVS) for the final 6 weeks (group 2)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pooled analysis after PVS
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Subjective symptom scores
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Self-limiting side effects
Number of subjects: 31
Study: 24053900

Group type: EXPERIMENTAL
Intervention: ST + SM + Ex
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ST + SM
Number of subjects: 15

Group type: COMPARATOR
Intervention: ST
Number of subjects: 15